肾素-血管紧张素-醛固酮系统与心力衰竭时的肾脏相互作用 - Suppr

Suppr

超能文献

Renin-angiotensin-aldosterone system and kidney interactions in heart failure.

作者信息

Ferreira João Pedro, Rossignol Patrick, Zannad Faiez

机构信息

Université de Lorraine, INSERM, France.

出版信息

J Renin Angiotensin Aldosterone Syst. 2019 Oct-Dec;20(4):1470320319889415. doi: 10.1177/1470320319889415.

DOI:10.1177/1470320319889415

PMID:31739737

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6864038/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e670/6864038/d8ec460cff0f/10.1177_1470320319889415-fig1.jpg

相似文献

Renin-angiotensin-aldosterone system and kidney interactions in heart failure.肾素-血管紧张素-醛固酮系统与心力衰竭时的肾脏相互作用

J Renin Angiotensin Aldosterone Syst. 2019 Oct-Dec;20(4):1470320319889415. doi: 10.1177/1470320319889415.

Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure.真实存在还是主观认知：高钾血症是心力衰竭中肾素 - 血管紧张素 - 醛固酮系统抑制的主要阻碍因素。

Nephron. 2018;138(3):173-175. doi: 10.1159/000485645. Epub 2017 Dec 5.

Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors.肾素-血管紧张素-醛固酮系统抑制剂临床指南与使用情况之间治疗差距的评估

Am J Manag Care. 2015 Sep;21(11 Suppl):S212-20.

Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.使用培多美索治疗可降低慢性肾脏病和肾素-血管紧张素系统抑制剂治疗高钾血症患者的醛固酮水平。

Kidney Int. 2016 Sep;90(3):696-704. doi: 10.1016/j.kint.2016.04.019. Epub 2016 Jun 24.

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.钾离子稳态和肾素-血管紧张素-醛固酮系统抑制剂。

Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11.

Hyperkalemia in the Hypertensive Patient.高血压患者的高钾血症。

Curr Cardiol Rep. 2018 Mar 1;20(2):12. doi: 10.1007/s11886-018-0954-2.

[Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].[高钾血症和肾素-血管紧张素-醛固酮系统抑制剂（RAASi）不依从性对心力衰竭或慢性肾脏病患者的影响]

G Ital Nefrol. 2019 Sep 24;36(5):2019-vol5.

PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.PEARL-HF研究：使用新型聚合钾结合剂RLY5016预防心力衰竭患者高钾血症

Future Cardiol. 2012 Jan;8(1):17-28. doi: 10.2217/fca.11.71.

Heart failure with reduced ejection fraction. Hyperkalemia and worsening renal function as challenges to implementation (guidelines vs real-world).射血分数降低的心力衰竭。高钾血症和肾功能恶化对指南实施（指南与现实世界）的挑战。

Nephrol News Issues. 2016 Apr;30(4):suppl 20-2, 31.

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.血钾升高事件后 RAASi 治疗不充分的临床影响。

BMC Nephrol. 2023 Jan 19;24(1):18. doi: 10.1186/s12882-022-03054-5.

引用本文的文献

Excess renin is attributed to the combination of forward and backward failure in HFrEF.过量肾素归因于 HFrEF 中的前向和后向衰竭的结合。

ESC Heart Fail. 2024 Jun;11(3):1748-1757. doi: 10.1002/ehf2.14731. Epub 2024 Mar 8.

Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome.肾素-血管紧张素-醛固酮系统在心脏-肾脏综合征发生和发展中的作用和机制。

J Renin Angiotensin Aldosterone Syst. 2022 Jan 24;2022:3239057. doi: 10.1155/2022/3239057. eCollection 2022.

Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway.青藤碱通过激活 Nrf2/ARE 信号通路改善心肌肥厚。

Bioengineered. 2021 Dec;12(2):12778-12788. doi: 10.1080/21655979.2021.2000195.

Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs.评估肾血管阻力指数作为 MMVD 犬亚临床心肾综合征发展标志物的诊断价值。

J Renin Angiotensin Aldosterone Syst. 2021 Jan-Dec;22(1):1470320321995082. doi: 10.1177/1470320321995082.

本文引用的文献

Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!

JACC Heart Fail. 2019 Jan;7(1):33-35. doi: 10.1016/j.jchf.2018.11.016.

Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.螺内酯治疗 HFpEF 合并慢性肾脏病患者的疗效和安全性。

JACC Heart Fail. 2019 Jan;7(1):25-32. doi: 10.1016/j.jchf.2018.10.017.

Cardiorenal Syndrome Revisited.再探心脏肾脏综合征。

Circulation. 2018 Aug 28;138(9):929-944. doi: 10.1161/CIRCULATIONAHA.117.028814.

Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap".

Am J Hypertens. 2018 Sep 11;31(10):1087-1089. doi: 10.1093/ajh/hpy107.

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists.新型盐皮质激素受体拮抗剂使用者高钾血症的发生率、预测因素和临床管理。

Eur J Heart Fail. 2018 Aug;20(8):1217-1226. doi: 10.1002/ejhf.1199. Epub 2018 Apr 18.

Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.螺内酯治疗射血分数保留的心力衰竭期间的事件性高钾血症、低钾血症和临床结局：TOPCAT 试验分析。

J Card Fail. 2018 May;24(5):313-320. doi: 10.1016/j.cardfail.2018.03.002. Epub 2018 Mar 20.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南特别工作组及美国心力衰竭学会的报告

Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.

Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation.TOPCAT研究中的螺内酯代谢物——区域差异的新见解

N Engl J Med. 2017 Apr 27;376(17):1690-1692. doi: 10.1056/NEJMc1612601.

The effects of short-term omission of daily medication on the pathophysiology of heart failure.短期停用日常药物对心力衰竭病理生理学的影响。

Eur J Heart Fail. 2017 May;19(5):643-649. doi: 10.1002/ejhf.748. Epub 2017 Mar 15.

Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.肾素-血管紧张素系统抑制、肾功能恶化及射血分数降低和保留的心力衰竭患者的预后：已发表研究数据的荟萃分析

Circ Heart Fail. 2017 Feb;10(2). doi: 10.1161/CIRCHEARTFAILURE.116.003588.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验